search
Back to results

BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial

Primary Purpose

Parkinson Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Frequency of physical therapy sessions
Sponsored by
University of Florida
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease focused on measuring Parkinson's Disease, Physical Therapy, Time Up and Go, Spaced Physical Therapy

Eligibility Criteria

30 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 30-90 years
  • Parkinson's disease as measured by Hoehn & Yahr stage 2-3
  • Idiopathic Parkinson's Disease patients diagnosed by a Movement Disorder Neurologist
  • Stable dopaminergic medication for 1 month prior to the study and during the study (6 month intervention)
  • Requires ongoing physical therapy as assessed by a physical therapist

Exclusion Criteria:

  • Comorbidities including orthopedic injuries or cardiopulmonary disease that would potentially interfere with physical therapy and assessments
  • Severe cognitive impairments (MMSE <21)
  • Unable to participate in all therapy sessions

Sites / Locations

  • Norman Fixel Institute for Neurological Diseases

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Burst group

Spaced Group

Arm Description

Patients received two physical therapy sessions weekly for 6 weeks.

Patients received one physical therapy sessions every 2 weeks for 6 months.

Outcomes

Primary Outcome Measures

Change between baseline and 6-month Timed Up and Go test (TUG)
The TUG test is a validated and reliable tool to assess balance and mobility in Parkinson's disease. It has been used as an outcome measure in many trials involving PT and exercise in PD and is frequently included in standard PT visits. Patients wear their regular footwear and can use a walking aid, if needed. Patient starts the test sitting back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor. Once examiner says go. the patient has to get up from the chair, walk until the line on the floor, come back and sit down on the chair. Timing begins when examiner says "go" and stops after patients sits back down. An older adult that takes 12 or more seconds to complete the task is at risk for falling.

Secondary Outcome Measures

Unified Parkinson's Disease Rating Scale (UPDRS) motor score
Minimum value for UPDRS part III is 0 and maximum value is 27. High scores mean a worse outcome.
The Mini Balance Evaluation Systems Test (MiniBesTest)
The MiniBesTest assesses dynamic balance: anticipatory postural adjustments, reactive postural control, sensory orientation and dynamic gait. It is a 14-item test scored on a 3 level ordinal scale. Minimum score is 0 and maximum score is 32. High scores mean better outcome.
10 meter walk test (10MWT)
This a performance measure used to assess walking speed in meters per second over a short distant.
Non-motor symptoms PD questionnaire (NMS)
NMS is a screening questionnaire comprising 30 items. It was not designed as a quantitative scale, however, a total score for the questionnaire is calculated by summing all the positive ("yes") responses. Minimum score is 0 and maximum score is 30. High scores correlate to worse outcomes. PD patients have higher scores when compared to control patients.
Parkinson's Disease Questionnaire-39 (PDQ39)
PDQ39 is a 39-item self reported questionnaire that assesses PD-specific health related quality over the last month. It assesses the 8 quality of life dimensions: mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication and bodily discomfort. Minimum score is 0 and maximum score is 156. High scores mean worse outcomes.
Levodopa equivalent daily doses (LEDD)
Conversion factor to generate a total Levodopa equivalent daily dose (LEDD), calculated as a sum of each parkinsonian medication. LEDD provides an artificial summary of the total daily medication a patient is receiving .
Baseline frequency of utilization of PT
Frequency of PT sessions patients were having before starting the study.
Objective gait analysis using Gaitrite
Patients walk on a 3m walking mat embedded with 256 sensors that are triggered when pressure is applied. The GAITRite system automates measuring temporal (timing) and spatial (distance) gait parameters (temporal/spatial) and 8 levels of relative pressure. Data are processed by a second compatible computer by using GaitMat software.
Falls diary
It consists in one way of recording fall frequency and the surrounding circumstances. Patients are encouraged to recall and identify the key circumstances surrounding falls.
Godin Leisure Activity Questionnaire
Patients have to disclose how many times on the average typical 7-Day period (a week) they do the following kinds of exercise for 15 or more minutes: STRENUOUS EXERCISE (HEART BEATS RAPIDLY) (e.g., running, jogging, hockey, football, soccer, squash, basketball, cross country skiing, judo, roller skating, vigorous swimming, vigorous long distance bicycling); MODERATE EXERCISE (NOT EXHAUSTING) (e.g., fast walking, baseball, tennis, easy bicycling, volleyball, badminton, easy swimming, alpine skiing, popular and folk dancing) and MILD/LIGHT EXERCISE (MINIMAL EFFORT) (e.g., yoga, archery, fishing from river bank, bowling, horseshoes, golf, snow-mobiling, easy walking). Weekly leisure activity score = (9 × Strenuous) + (5 × Moderate) + (3 × Light). Minimum score is 0. Maximum score is 119. High scores mean that the patient is more active. Patients can be classified as sedentary (<14), moderately active (14-23) and active (24 or more).
Change between 6-week and 6-month Timed Up and Go test (TUG)
The TUG test is a validated and reliable tool to assess balance and mobility in Parkinson's disease. It has been used as an outcome measure in many trials involving PT and exercise in PD and is frequently included in standard PT visits. Patients wear their regular footwear and can use a walking aid, if needed. Patient starts the test sitting back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor. Once examiner says go. the patient has to get up from the chair, walk until the line on the floor, come back and sit down on the chair. Timing begins when examiner says "go" and stops after patients sits back down. An older adult that takes 12 or more seconds to complete the task is at risk for falling.

Full Information

First Posted
December 14, 2021
Last Updated
January 4, 2022
Sponsor
University of Florida
search

1. Study Identification

Unique Protocol Identification Number
NCT05180747
Brief Title
BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial
Official Title
A Randomized Trial of BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
August 3, 2020 (Actual)
Primary Completion Date
October 1, 2021 (Actual)
Study Completion Date
October 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Florida

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Many patients with Parkinson's Disease (PD) will encounter difficulties with balance, posture, and gait for which physical therapy (PT) has been shown to be beneficial. The purpose of this study is to randomize patients between standard "burst" PT versus "spaced" PT to inform on the optimal frequency of PT for PD patients. Burst PT in this study was defined as 2 PT visits per week for 6 weeks (12 sessions) and spaced PT, as 1 PT visit every other week for 6 months (12 sessions).
Detailed Description
Parkinson's Disease (PD) is a progressive neurodegenerative disorder with a negative impact on quality of life.1 Many patients with PD will encounter difficulties with balance, posture, transfer, gait and physical capacity due to the motor symptoms of the disease.2 For these symptoms, physical therapy (PT) has been shown to be beneficial and clinically useful for the motor symptoms and thus is routinely prescribed alongside medical management. However, despite increasing evidence of the positive effects of physical therapy for patients with PD, there is no standard approach for organizing physiotherapy in the context of multidisciplinary care. Administration of physical therapy as a "burst" of frequent sessions delivered over 4-6 weeks is the most commonly employed strategy in PD patients and is driven largely by the payer system. Burst therapy has been useful in post-stroke and post traumatic brain injury rehabilitation, however, the investigators of this study hypothesize that this approach will be suboptimal in PD when compared to therapy which is "spaced" over a longer period of time. The purpose of this study is to randomize patients between typical "burst" PT versus "spaced" PT to inform on the optimal frequency of PT for PD patients. Burst PT in this study was defined as 2 PT visits per week for 6 weeks (12 sessions) and spaced PT, as 1 PT visit every other week for 6 months (12 sessions). 30 PD patients were recruited as part of a pilot trial to assess the effectiveness of burst vs. spaced physical therapy (the BUS PT trial). Baseline measures were collected on all patients, including the timed up and go test (TUG), the baseline frequency of utilization of PT, falls, fractures, hospitalizations, the 10 meter walk test (10MWT), the Mini Balance Evaluation Systems Test (miniBESTest), objective gait analysis using Gaitrite, the Parkinson's Disease Questionnaire-39 (PDQ39), the Unified Parkinson's Disease Rating Scale (UPDRS) "ON" and "OFF" motor scores, the quantitation of the levodopa equivalent daily doses (LEDD), and the Godin Leisure Activity Questionnaire to assess baseline exercise levels. The investigators hypothesized that "spaced" PT is beneficial for maintenance of physical function in PD. Prior collective evidence suggests that long-term continuous exercise in PD patients is associated with positive outcomes, however a spaced PT approach has not been employed. This study will provide useful data that will directly impact payer systems, reimbursements and access to care for PD patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
Parkinson's Disease, Physical Therapy, Time Up and Go, Spaced Physical Therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Single-blinded study. Participants were randomly assigned (1:1) to either burst or spaced groups using a computer random generated sequence. Group allocation could not be hidden from the study participant and thus once baseline measurements were recorded, a disclosure of assignment was made by the study PI. Patients Outcomes measures were be performed at baseline and 6 months by a blinded rater.
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Burst group
Arm Type
Other
Arm Description
Patients received two physical therapy sessions weekly for 6 weeks.
Arm Title
Spaced Group
Arm Type
Other
Arm Description
Patients received one physical therapy sessions every 2 weeks for 6 months.
Intervention Type
Other
Intervention Name(s)
Frequency of physical therapy sessions
Intervention Description
Physical therapy sessions consisted of standard of care practice at our center of excellence i two different frequencies. All patients in both groups received 12 physical therapy sessions. Patients in the burst group received 2 physical therapy sessions per week in 6 weeks, while patients in the spaced group received 1 session every 2 weeks for 6 months.
Primary Outcome Measure Information:
Title
Change between baseline and 6-month Timed Up and Go test (TUG)
Description
The TUG test is a validated and reliable tool to assess balance and mobility in Parkinson's disease. It has been used as an outcome measure in many trials involving PT and exercise in PD and is frequently included in standard PT visits. Patients wear their regular footwear and can use a walking aid, if needed. Patient starts the test sitting back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor. Once examiner says go. the patient has to get up from the chair, walk until the line on the floor, come back and sit down on the chair. Timing begins when examiner says "go" and stops after patients sits back down. An older adult that takes 12 or more seconds to complete the task is at risk for falling.
Time Frame
Baseline up to 6-month follow up
Secondary Outcome Measure Information:
Title
Unified Parkinson's Disease Rating Scale (UPDRS) motor score
Description
Minimum value for UPDRS part III is 0 and maximum value is 27. High scores mean a worse outcome.
Time Frame
Baseline up to 6-month follow up
Title
The Mini Balance Evaluation Systems Test (MiniBesTest)
Description
The MiniBesTest assesses dynamic balance: anticipatory postural adjustments, reactive postural control, sensory orientation and dynamic gait. It is a 14-item test scored on a 3 level ordinal scale. Minimum score is 0 and maximum score is 32. High scores mean better outcome.
Time Frame
Baseline up to 6-month follow up
Title
10 meter walk test (10MWT)
Description
This a performance measure used to assess walking speed in meters per second over a short distant.
Time Frame
Baseline up to 6-month follow up
Title
Non-motor symptoms PD questionnaire (NMS)
Description
NMS is a screening questionnaire comprising 30 items. It was not designed as a quantitative scale, however, a total score for the questionnaire is calculated by summing all the positive ("yes") responses. Minimum score is 0 and maximum score is 30. High scores correlate to worse outcomes. PD patients have higher scores when compared to control patients.
Time Frame
Baseline up to 6-month follow up
Title
Parkinson's Disease Questionnaire-39 (PDQ39)
Description
PDQ39 is a 39-item self reported questionnaire that assesses PD-specific health related quality over the last month. It assesses the 8 quality of life dimensions: mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication and bodily discomfort. Minimum score is 0 and maximum score is 156. High scores mean worse outcomes.
Time Frame
Baseline up to 6-month follow up
Title
Levodopa equivalent daily doses (LEDD)
Description
Conversion factor to generate a total Levodopa equivalent daily dose (LEDD), calculated as a sum of each parkinsonian medication. LEDD provides an artificial summary of the total daily medication a patient is receiving .
Time Frame
Baseline up to 6-month follow up
Title
Baseline frequency of utilization of PT
Description
Frequency of PT sessions patients were having before starting the study.
Time Frame
Baseline up to 6-month follow up
Title
Objective gait analysis using Gaitrite
Description
Patients walk on a 3m walking mat embedded with 256 sensors that are triggered when pressure is applied. The GAITRite system automates measuring temporal (timing) and spatial (distance) gait parameters (temporal/spatial) and 8 levels of relative pressure. Data are processed by a second compatible computer by using GaitMat software.
Time Frame
Baseline up to 6-month follow up
Title
Falls diary
Description
It consists in one way of recording fall frequency and the surrounding circumstances. Patients are encouraged to recall and identify the key circumstances surrounding falls.
Time Frame
Baseline up to 6-month follow up
Title
Godin Leisure Activity Questionnaire
Description
Patients have to disclose how many times on the average typical 7-Day period (a week) they do the following kinds of exercise for 15 or more minutes: STRENUOUS EXERCISE (HEART BEATS RAPIDLY) (e.g., running, jogging, hockey, football, soccer, squash, basketball, cross country skiing, judo, roller skating, vigorous swimming, vigorous long distance bicycling); MODERATE EXERCISE (NOT EXHAUSTING) (e.g., fast walking, baseball, tennis, easy bicycling, volleyball, badminton, easy swimming, alpine skiing, popular and folk dancing) and MILD/LIGHT EXERCISE (MINIMAL EFFORT) (e.g., yoga, archery, fishing from river bank, bowling, horseshoes, golf, snow-mobiling, easy walking). Weekly leisure activity score = (9 × Strenuous) + (5 × Moderate) + (3 × Light). Minimum score is 0. Maximum score is 119. High scores mean that the patient is more active. Patients can be classified as sedentary (<14), moderately active (14-23) and active (24 or more).
Time Frame
Baseline up to 6-month follow up
Title
Change between 6-week and 6-month Timed Up and Go test (TUG)
Description
The TUG test is a validated and reliable tool to assess balance and mobility in Parkinson's disease. It has been used as an outcome measure in many trials involving PT and exercise in PD and is frequently included in standard PT visits. Patients wear their regular footwear and can use a walking aid, if needed. Patient starts the test sitting back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor. Once examiner says go. the patient has to get up from the chair, walk until the line on the floor, come back and sit down on the chair. Timing begins when examiner says "go" and stops after patients sits back down. An older adult that takes 12 or more seconds to complete the task is at risk for falling.
Time Frame
6-week follow up (burst group only) and 6-month follow up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 30-90 years Parkinson's disease as measured by Hoehn & Yahr stage 2-3 Idiopathic Parkinson's Disease patients diagnosed by a Movement Disorder Neurologist Stable dopaminergic medication for 1 month prior to the study and during the study (6 month intervention) Requires ongoing physical therapy as assessed by a physical therapist Exclusion Criteria: Comorbidities including orthopedic injuries or cardiopulmonary disease that would potentially interfere with physical therapy and assessments Severe cognitive impairments (MMSE <21) Unable to participate in all therapy sessions
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ka Loong Kelvin Au, MD
Organizational Affiliation
University of Kansas Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Norman Fixel Institute for Neurological Diseases
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32608
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures and appendices), study protocol and statistical analysis plan will be shared with researchers who provide a methodologically sound proposal to achieve aims in the approved proposal. Proposals should be submitted up to 36 months following article publication. After 36 months, data will be available in our University's data warehouse, but without investigator support other than deposited metadata. Proposals should be directed to janinelobolopes@ufl.edu.
IPD Sharing Time Frame
Beginning 3 months and ending 36 months following article publication
IPD Sharing Access Criteria
Researchers who provide a methodologically sound proposal to achieve aims in the approved proposal

Learn more about this trial

BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial

We'll reach out to this number within 24 hrs